De novo variants in SLC12A6 cause sporadic early-onset progressive sensorimotor neuropathy

Specialty Areas:
Date: September 27, 2019
Authors:
Alexander Grimm, Annette Weichselbaum, Bianca R Flores, Eric Delpire, Hanna Kuepper, Joohyun Park, Katalin Scherer, Katrin Rupprich, Marc Sturm, Maren Rautenberg, Mari Rossi, Natalie Deininger, Tobias B Haack, Ute Grasshoff
Journal: BMJ

Abstract

Background

Charcot-Marie-Tooth disease (CMT) is a clinically and genetically heterogeneous disorder of the peripheral nervous system. Biallelic variants in SLC12A6 have been associated with autosomal-recessive hereditary motor and sensory neuropathy with agenesis of the corpus callosum (HMSN/ACC). We identified heterozygous de novo variants in SLC12A6 in three unrelated patients with intermediate CMT.

Methods

We evaluated the clinical reports and electrophysiological data of three patients carrying de novo variants in SLC12A6 identified by diagnostic trio exome sequencing. For functional characterisation of the identified variants, potassium influx of mutated KCC3 cotransporters was measured in Xenopus oocytes.

Results

We identified two different de novo missense changes (p.Arg207His and p.Tyr679Cys) in SLC12A6 in three unrelated individuals with early-onset progressive CMT. All presented with axonal/demyelinating sensorimotor neuropathy accompanied by spasticity in one patient. Cognition and brain MRI were normal. Modelling of the mutant KCC3 cotransporter in Xenopus oocytes showed a significant reduction in potassium influx for both changes.

Conclusion

Our findings expand the genotypic and phenotypic spectrum associated with SLC12A6 variants from autosomal-recessive HMSN/ACC to dominant-acting de novo variants causing a milder clinical presentation with early-onset neuropathy.